About Research Partnership
The world's largest independent healthcare market research and consulting agency
Research Partnership is the largest independent healthcare market research and consulting agency in the world.
We collaborate with clients from the global pharmaceutical, medtech and biotech industries, providing research intelligence and strategic recommendations that elevate healthcare brands and help them thrive in a complex and challenging environment.
We are specialists in healthcare and passionate about what we do. Our independence allows us to deliver a truly bespoke and responsive service. Our highly experienced senior team is supported by talented, professionally-trained researchers located across our global offices.
Combining evidence with expertise, we bridge the gap between research and consultancy.
Our clients see us as a valued partner, working together to resolve their business
challenges, maximise their competitiveness,
transform their brands, and power their success.
- Some example case studiesHow we helped our client identify where to play and how to win for their hospital product in India
The challenge:Our client has a hospital care portfolio which is marketed globally. Despite a low per capita use of the product in India, the annual growth rate of usage is among the highest in the world. It was therefore critical for our client to understand which channels they should focus on (where to play) and what points of differentiation would enable them to gain market…read more »How we uncovered unmet needs using social media listening
The challenge: Our client wanted to further their understanding of the impacts a long-term rare skin condition can have on patients by exploring the patient journey. Market research was required to identify opportunities for improving the patient experience and inform the brand strategy for their product. The solution: We began by conducting exploratory research using social media listening to review the online commentary and get…read more »How we helped our client understand current and future combination pricing strategies in the Multiple Myeloma market
The challengeOur client had their product for multiple myeloma (MM) approved in several lines of therapy combined with different backbones. Their product was also being studied in some other indications with additional backbones and was anticipated to receive approval in the coming years. With several other competitive therapies available on the market, including many branded combination products, our client anticipated that payers might start considering…read more »
- Our latest awardsRichard Head presented with MR Excellence award at EphMRA Conference
We were delighted to exhibit, sponsor and present three papers at the EphMRA conference where Director Richard Head was presented with the runner-up award for ‘Business Impact through Innovation’.read more »Research Partnership and Janssen awarded runner-up in the EphMRA MR Excellence Awards
We are delighted to announce that an entry submitted by Janssen and Research Partnership for the 2019 EphMRA MR Excellence Awards has been awarded runner-up in the ‘Business Impact through Innovation’ category.read more »Janssen & Research Partnership win prestigious BHBIA Best Business Impact award
We are delighted to announce that Janssen and Research Partnership have won the BOBI (Best of Business Intelligence) Award in the Best Business Impact category at the BHBIA annual conference in London for our collaborative market research and consultancy work. The ‘Best Business Impact’ category, sponsored by Branding Science, is awarded for insights which have significantly increased a client's understanding of one or more of their…read more »